Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - GROSS PROFIT
Gross Profit NBIX - Neurocrine Biosciences, Inc.
2.32 B
LAST VALUE
25.86%
2 YEAR CAGR
24.35%
5 YEAR CAGR
66.45%
10 YEAR CAGR